drugset / Trial / NCT00861549

Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers

NCT00861549 ↗

Phase 1 Completed 32 enrolled PhytoHealth Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to evaluate the bioavailability of two formulations (Taiwan and China mainland) of phencynonate hydrochloride tablets and to generate pharmacokinetic and safety profiles of phencynonate hydrochloride in healthy volunteers.

Timeline

Start
2008-08
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Phencynonate Small molecule 1 mg —
Subject Phencynonate Small molecule 2 mg —
Subject Phencynonate Small molecule 4 mg —

Indications

No indication recorded.